Zdrowie i gospodarka · 30/09/2019

FDA Announces Fee Rates for Tropical Disease Priority Review Voucher for Fiscal Year 2020

The Food and Drug Administration (FDA) has set the fee rates for using a tropical disease priority review voucher for the fiscal year 2020, as mandated by the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Food and Drug Administration Amendments Act of 2007 (FDAAA).